Clinical Associations with the differences in rivaroxaban dosing in patients with atrial fibrillation stratified by three renal function formulae

BACKGROUND: Clinical trials used Cockcroft-Gault (CG) formula to calculate the estimated glomerular filtration rate (eGFR) in order to dose rivaroxaban for patients with atrial fibrillation (AF). OBJECTIVES: The aim of this study is to evaluate rivaroxaban dosing appropriateness in patients with AF...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Maqbali, Juhaina Salim, Alawi, Abdullah M. Al, Al-Adawi, Maria, Al-Falahi, Zubaida, Al-Azizi, Asia, Al Badi, Kholoud, Rawahi, Mohamed Al
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117315/
https://www.ncbi.nlm.nih.gov/pubmed/37090449
http://dx.doi.org/10.18549/PharmPract.2023.1.2758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117315/
https://www.ncbi.nlm.nih.gov/pubmed/37090449
http://dx.doi.org/10.18549/PharmPract.2023.1.2758

Ejemplares similares